USPTO serial 88985129
EVERNORTH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 25, 2023
- Examiner
- PURATH, ANICKA S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EVERNORTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Express Scripts Strategic Development, Inc.
St. Louis, MO
Other trademarks owned by Express Scripts Strategic Development, Inc.
Express Scripts Strategic Development, Inc.
St. Louis, MO
Other trademarks owned by Express Scripts Strategic Development, Inc.
Express Scripts Strategic Development, Inc.
St. Louis, MO
Other trademarks owned by Express Scripts Strategic Development, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DENNIS S. PRAHL
DENNIS S. PRAHL LADAS & PARRY LLP1040 AVENUE OF THE AMERICASNEW YORK, NY 10018UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Mail order and wholesale pharmacy services; cost management and containment for the health, prescription drug and medical benefit plans of others; prescription drug formulary cost management services; business consulting services regarding healthcare costs, benefits and pharmacy services; business services provided to the healthcare industry for business purposes, namely, business data analyzing and reporting services in the fields of healthcare, pharmaceuticals, and consumer behavior; drug and healthcare utilization and review services; medical care cost management for the health, medical and prescription drug plans of others; providing a web based online portal featuring medical cost management data and analytics information related to the pharmaceutical, medical, healthcare, and life sciences fields; computerized database management and data processing services in the pharmaceutical, medical, healthcare, healthcare insurance and health plan benefits, and life sciences fields; electronic data collection and data submission services for business purposes in the fields of medicine, life sciences, insurance and healthcare; insurance and health plan benefits claims auditing relating to fraud waste and abuse; tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use, medical care, and healthcare habits, to identify potential cost savings and clinical benefits; Collection and analysis of quality metric data for health care providers, insurance companies and health care payors for business purposes; cost management of health care services provided by others; business consulting in the fields of organization and coordination of health care services | ACTIVE | Sep 16, 2020 |
| 036 | Medical benefit management services; pharmacy benefit management services; medical insurance case and utilization review and insurance claims adjustment services for healthcare purchasers and payors and providers; administration of managed health care plans and pharmacy and medical benefit plans; Financial risk analysis and evaluation services relating to identifying and estimating future potential health costs, and likelihood of clinical outcomes; insurance underwriting in the fields of life, medical, and health | ACTIVE | Sep 16, 2020 |
| 042 | Software as a service (SaaS) services featuring software for medical utilization review, reporting and verification; software as a service (SaaS) services featuring software for optimizing healthcare utilization and financial risk for healthcare payers, assisting physicians in making clinical decisions, and analyzing data to help health care providers track clinical decisions and develop best practices; providing online non-downloadable software for use in managing the quality and cost of healthcare; providing online non-downloadable software for use in obtaining prior authorizations; software as a service (SaaS) services featuring software for use in managing medical and pharmacy benefits; providing online, non-downloadable, software application for medical billing for physicians and health care institutions; providing online, non-downloadable software for use in the data analytics field; application services provider, namely, hosting, managing, developing, analyzing, and maintaining applications, software and web sites for use by others in the fields of healthcare benefits programs, employee productivity and risk management; online, non-downloadable computer software used for accessing, collecting, managing, tracking, analyzing, and reporting data in the pharmaceutical, medical, healthcare, and life sciences fields and in the field of insurance and benefits; providing temporary use of online, non-downloadable software for collection and management of healthcare and life sciences data; providing temporary use of online, non-downloadable computer software for collecting, managing, and analyzing clinical trial data; providing temporary use of online non-downloadable software for health risk assessment and profiling for use in the field of preventative health; health data warehousing and consulting services; data mining and data mining consulting services; providing temporary use of non-downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information in the field of healthcare | ACTIVE | Sep 16, 2020 |
| 044 | Advisory services and consultancy regarding healthcare; managed healthcare services; health care services, namely, disease management programs; behavioral health services; providing information to patients in the field of administering medications and health care; genetic counseling; health consulting in the pharmaceutical, medical, healthcare, and life sciences fields; in home health care and in home health testing, namely, providing medical testing of fitness and medical consultations to individuals to help them make health, wellness, and nutritional changes in their daily living to improve health and lower costs | ACTIVE | Sep 16, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Express Scripts Strategic Development, Inc.
- Other trademarks owned by Express Scripts Strategic Development, Inc.
- Other trademarks owned by Express Scripts Strategic Development, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EVERNORTH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 25, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 25, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 21, 2023 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jun 20, 2023 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 26, 2023 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 26, 2023 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| May 23, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 5, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 4, 2023 | IUAF | USE AMENDMENT FILED | — |
| May 4, 2023 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| May 4, 2023 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 4, 2023 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| May 3, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 3, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 3, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 3, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 1, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 1, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 1, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 5, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 3, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 3, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 3, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 28, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 26, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 26, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 26, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 4, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 28, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 27, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 27, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 27, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 27, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 14, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 4, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 24, 2020 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Aug 16, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jul 28, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jun 24, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 6, 2020 | NWAP | NEW APPLICATION ENTERED | — |